Roquette

Unlock the potential of high-purity methylcellulose in biotech. Join our upcoming webinar to explore how METHONOVA™ enhances cell culture performance and supports safer cryopreservation.

https://www.pharmtech.com/pt_w/cell-culture

Biotech and bioprocessing workflows are evolving rapidly, and innovation in supplements and additives are playing a critical role in enabling safer, more efficient cell culture and cryopreservation processes. This webinar introduces METHONOVA™, NovaMatrix's high-purity, biopharma-grade methylcellulose designed for biopharmaceutical applications. Attendees will gain insights into the fundamentals of methylcellulose, its historical use in biotech, and the key differentiating features that make METHONOVA™ a reliable choice for regulated environments. The session will explore how METHONOVA™ supports enhanced Chinese Hamster Ovary (CHO) cell productivity, improves filterability, and offers strong cell compatibility, all while meeting rigorous quality standards. Applicable reactor studies and cryopreservation data will be shared, along with a look at upcoming projects and application studies. Whether you're working in upstream development or scaling bioprocesses, this webinar offers valuable data and practical knowledge to help optimize your workflows.

Gain a foundational understanding of methylcellulose and its role in biopharmaceutical applications, including historical use and current relevance in cell culture and cryopreservation.

Explore the unique features of METHONOVA™, including its high purity, Good Manufacturing Practice (GMP) compliance, and performance benefits such as filterability, cell compatibility, and autoclavability.

Review data and case studies demonstrating METHONOVA™’s impact on CHO cell productivity and bioprocessing efficiency, with insights into upcoming applications.

Biotech and Biopharma R&D Scientists seeking innovative additive solutions for cell culture and cryopreservation.

Formulation and Media Developers looking to optimize performance and consistency in biotech workflows.

Quality Assurance Specialists focused on high-purity, GMP-compliant materials for regulated environments.

Process Development Engineers involved in scaling and improving bioprocessing efficiency.



R&D Director
Roquette’s Health & Pharma Solutions Business Group

 is R&D Director at Roquette’s Health & Pharma Solutions Business Group. With a Ph.D. in Bioengineering, his career spans Dow and DuPont, where he led formulation science across pharma and industrial sectors. At Roquette, he drives innovation in biopharmaceutical production, with multiple patents, publications, and industry awards to his name.




Sr. Applications Scientist
Roquette's Health & Pharma Solutions Business Group

, Sr. Applications Scientist at Roquette’s Health & Pharma Solutions Business Group, holds a Ph.D. in Polymer Chemistry and brings deep expertise in material and formulation science. Her work focuses on excipient innovation and strategic formulation for oral dosage form and biopharma applications.


Webcasts

Webinar Date/Time:  Thu, Dec 11, 2025 11:00 AM EST

METHONOVA™: Enhancing Cell Culture Growth and Productivity with High Purity Methylcellulose

Meet the Roquette pharma team at CPhI Worldwide this year, they have many news to share!


	Continuously seeking for better serving its customers worldwide, Roquette has recently enlarged its portfolio of solutions thanks to the acquisition agreement of ITACEL, a leading player in Brazil and Latin America.
	ITACEL is BLANVER’ shareholders excipients division. This acquisition will enable to create new opportunities for both ROQUETTE and ITACEL’s customers and employees and to be positioned as a global leader in natural-based pharmaceutical excipients solutions with 4 new ranges of products now available:

		-MICROCEL®, a partially depolymerized cellulose;

-SOLUTAB®, a highly efficient superdisintegrant;

-TABULOSE® SC, a co-processed product composed of Microcrystalline Cellulose (MCC) and Sodium

-EXPLOSOL®, a superdisintegrant with an action mechanism based on water absorption.

, Roquette is ready to help formulators bringing new biologics to life.
	Thanks to a unique 

 for both upstream and downstream applications.
	Four new brands coming to the market under the names LYCADEX

 BioPharma sorbitol and Dextrose Anhydrous BioPharma.

Opening a new facility in Singapore in the fall of 2017:


	A new Research & Development and Customer Technical Service facility in Singapore will complement ROQUETTE’s deep expertise in formulation and application science, giving customers throughout Asia the ability to receive localized project support and in-depth application training.

	The new R&D and CTS facility will be a key asset to support the ROQUETTE’s Pharma Business Unit growth ambitions, and there are 

	From oral dosage excipients (Rx, Gx, nutraceuticals & OTC) and biopharma materials to injectables and dialysis solutions, Roquette is holding itself to the highest industry standards - providing consistency and reliability across every ingredient.

	To learn more about our latest news, come and visit us on our booth for a 

(*) Biopharma: The Protein-based drugs can be game-changing by having the ability to put rheumatoid arthritis into remission and transform many cancers into treatable conditions.

A family-owned Group serving customers globally, Roquette is a leader in specialty food ingredients and pharmaceutical excipients. The products and solutions developed by the Group deliver proven technological, nutritional and health benefits precisely tailored to the pharma, nutrition, food and selected industry markets. Roquette’s offer is produced from plant-based raw materials such as corn, wheat, potatoes and peas. Since its foundation over 80 years ago, the Group’s growth has been based on innovation, a passion for the job and a commitment to achieve. Roquette operates in over 100 countries, has a turnover of around 3.2 billion euros and currently employs more than 8,300 people worldwide.

Roquette

Articles